HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions.
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Bruford, Elspeth A https://orcid.org/0000-0002-8380-5247
Antonescu, Cristina R
Carroll, Andrew J https://orcid.org/0000-0001-9844-730X
Chinnaiyan, Arul
Cree, Ian A
Abstract
Gene fusions have been discussed in the scientific literature since they were first detected in cancer cells in the early 1980s. There is currently no standardized way to denote the genes involved in fusions, but in the majority of publications the gene symbols in question are listed either separated by a hyphen (-) or by a forward slash (/). Both types of designation suffer from important shortcomings. HGNC has worked with the scientific community to determine a new, instantly recognizable and unique separator-a double colon (::)-to be used in the description of fusion genes, and advocates its usage in all databases and articles describing gene fusions.
Description
Keywords
Consensus, Databases, Genetic, Genomics, Guidelines as Topic, Humans, Leukemia, Oncogene Proteins, Fusion, Terminology as Topic
Is Part Of
Publisher
Springer Science and Business Media LLC
Publisher DOI
Sponsorship
Wellcome Trust (Wellcome) (208349/Z/17/Z)
U.S. Department of Health & Human Services | National Institutes of Health (NIH) (U24HG003345)
U.S. Department of Health & Human Services | National Institutes of Health (NIH) (U24HG003345)